Vitamin D supplementation demonstrated potential benefits for oncology patients, mitigating the side effects of chemotherapy (CT) and radiotherapy (RT) while supporting bone health, according to a study published in Nutrients.

Despite the heterogeneity of methodologies across studies, evidence suggested that vitamin D plays a critical role in reducing treatment-associated adverse events, such as

  • peripheral neuropathy,
  • nausea,
  • and fatigue.

In addition, maintaining adequate levels of vitamin D may help preserve bone density, particularly in patients undergoing preoperative chemoradiotherapy.